Rerouting the drug response: Overcoming metabolic adaptation in KRAS-mutant cancers | Science Signaling

Targeting KRAS-induced metabolic rewiring in the cells in and around the tumor can restore drug sensitivity.
Source: Signal Transduction Knowledge Environment - Category: Science Source Type: news